Key result
Type 2 diabetes mellitus was associated with significantly different fat fractions in the liver and pancreas, and visceral adipose tissue area compared to healthy controls (P<0.05).
Why the study?
Obesity causes ectopic fat deposits in the liver and pancreas that influence insulin resistance and glucose elevation in type 2 diabetes, prompting assessment of these relationships using MR Dixon fat fraction quantification.
Does the MR Dixon technique reveal differences in liver and pancreas fat fraction between T2DM patients and healthy controls across different BMI categories?
Cross-Sectional (n=157)
Does the MR Dixon technique reveal differences in liver and pancreas fat fraction between T2DM patients and healthy controls across different BMI categories?
p-value: p=<0.05
The MR Dixon technique demonstrates that tissue fat fraction in the liver and pancreas is significantly associated with T2DM, independent of BMI.
MR Dixon supports BMI-independent ectopic fat assessment in T2DM; hypothesis-generating for phenotyping and requires prospective validation.
Objective . The increased obesity results in ectopic fat deposits in liver and pancreas, which will affect insulin resistance and elevated plasma glucose with type 2 diabetes. To assess the relationship between obesity and ectopic fat deposits and diabetes, this study used the MR Dixon method for the quantification of liver and pancreas fat fraction (FF) in type 2 diabetes mellitus (T2DM) patients and healthy controls. Methods . The FF of whole liver (FFWL) and pancreas (FFWP), the maximum diameters of the pancreas, the abdominal subcutaneous adipose area (SAT), the visceral adipose tissue area (VAT), and the total abdominal adipose tissue area (TAT) were measured for 157 subjects using the MR Dixon data. Four groups were established on the basis of BMI value. For statistics, intra‐ and intergroup comparisons were made by employing independent sample t ‐test. Results . FFWL, FFWP, and VAT varied significantly between T2DM (BMI < 25) and control group (BMI < 25), T2DM (BMI ≥ 25) and control group (BMI ≥ 25), T2DM (BMI < 25) and T2DM (BMI ≥ 25) (all P < 0.05). The FF of pancreas tail, SAT, and TAT varied significantly between control group (BMI < 25) and control group (BMI ≥ 25) ( P < 0.05). FFWP and the FF of pancreas tail varied significantly between T2DM and normal volunteers ( P < 0.05), with normal or mild liver fat content. Conclusion . The tissue FF, which has a close relationship with T2DM, can be assessed by the MR Dixon technique. T2DM patients should pay attention to tissue fat content regardless of BMI values.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2022) conducted a cross-sectional in Type 2 diabetes mellitus (n=157). Type 2 diabetes mellitus vs. Healthy controls was evaluated on Fat fraction of whole liver and pancreas, and visceral adipose tissue area (p=<0.05). Type 2 diabetes mellitus was associated with significantly different fat fractions in the liver and pancreas, and visceral adipose tissue area compared to healthy controls (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: